Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) Other Noncash Income (Expense)

2.2 / 5 stars · 48/110 Roast Me

BRISTOL-MYERS SQUIBB COMPANY Other Noncash Income (Expense)

BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Noncash Income (Expense) of -$22.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-30

  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for the quarter ending 2026-06-30 was -$1.00M, a 114.29% decline year-over-year.
  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for the quarter ending 2026-03-31 was -$21.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for the quarter ending 2025-12-31 was -$308.00M, a 1162.07% decline year-over-year.
  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for the quarter ending 2025-09-30 was $74.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for fiscal 2025 was -$232.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for fiscal 2024 was -$94.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for fiscal 2023 was -$300.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other noncash income (expense) for fiscal 2022 was -$223.00M.
Period endOther Noncash Income (Expense) 3 monthOther Noncash Income (Expense) 3 month as first filedOther Noncash Income (Expense) 6 monthOther Noncash Income (Expense) 6 month as first filedOther Noncash Income (Expense) 9 monthOther Noncash Income (Expense) 9 month as first filedOther Noncash Income (Expense) 12 monthOther Noncash Income (Expense) 12 month as first filed
2026-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$22.00M
10-Q · filed 2026-07-30
-$330.00M
derived: sum of 3 quarters · filed 2026-07-30
-$256.00M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$21.00M
10-Q · filed 2026-04-30
-$329.00M
derived: sum of 2 quarters · filed 2026-04-30
-$255.00M
derived: sum of 3 quarters · filed 2026-04-30
-$248.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31-$308.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
-$234.00M
derived: sum of 2 quarters · filed 2026-02-11
-$227.00M
derived: sum of 3 quarters · filed 2026-07-30
-$232.00M
10-K · filed 2026-02-11
2025-09-30$74.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$81.00M
derived: sum of 2 quarters · filed 2026-07-30
$76.00M
10-Q · filed 2025-10-30
$105.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$7.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$2.00M
10-Q · filed 2026-07-30
$31.00M
derived: sum of 3 quarters · filed 2026-07-30
-$72.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$5.00M
10-Q · filed 2026-04-30
-$10.00M
10-Q · filed 2025-04-24
$24.00M
derived: sum of 2 quarters · filed 2026-04-30
-$79.00M
derived: sum of 3 quarters · filed 2026-04-30
-$76.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$29.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
-$74.00M
derived: sum of 2 quarters · filed 2026-02-11
-$71.00M
derived: sum of 3 quarters · filed 2026-02-11
-$94.00M
10-K · filed 2026-02-11
2024-09-30-$103.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$100.00M
derived: sum of 2 quarters · filed 2025-10-30
-$123.00M
10-Q · filed 2025-10-30
-$163.00M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$3.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$20.00M
10-Q · filed 2025-07-31
-$60.00M
derived: sum of 3 quarters · filed 2026-02-11
-$329.00M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31-$23.00M
10-Q · filed 2025-04-24
-$22.00M
10-Q · filed 2024-04-25
-$63.00M
derived: sum of 2 quarters · filed 2026-02-11
-$332.00M
derived: sum of 3 quarters · filed 2026-02-11
-$319.00M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31-$40.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
-$309.00M
derived: sum of 2 quarters · filed 2026-02-11
-$296.00M
derived: sum of 3 quarters · filed 2026-02-11
-$300.00M
10-K · filed 2026-02-11
-$308.00M
10-K · filed 2024-02-13
2023-09-30-$269.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
-$256.00M
derived: sum of 2 quarters · filed 2024-10-31
-$260.00M
10-Q · filed 2024-10-31
-$304.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$13.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26
$9.00M
10-Q · filed 2024-07-26
-$35.00M
derived: sum of 3 quarters · filed 2025-02-12
$5.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31-$4.00M
10-Q · filed 2024-04-25
-$48.00M
derived: sum of 2 quarters · filed 2025-02-12
-$8.00M
derived: sum of 3 quarters · filed 2025-02-12
$29.00M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31-$44.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
-$4.00M
derived: sum of 2 quarters · filed 2025-02-12
$33.00M
derived: sum of 3 quarters · filed 2025-02-12
-$223.00M
10-K · filed 2025-02-12
-$232.00M
10-K · filed 2023-02-14
2022-09-30$40.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26
$77.00M
derived: sum of 2 quarters · filed 2023-10-26
-$179.00M
10-Q · filed 2023-10-26
-$178.00M
10-Q · filed 2022-10-26
-$158.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-06-30$37.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27
-$219.00M
10-Q · filed 2023-07-27
-$218.00M
10-Q · filed 2022-07-27
-$198.00M
derived: sum of 3 quarters · filed 2024-02-13
-$167.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-03-31-$256.00M
10-Q · filed 2023-04-27
-$248.00M
10-Q · filed 2022-04-29
-$235.00M
derived: sum of 2 quarters · filed 2024-02-13
-$204.00M
derived: sum of 3 quarters · filed 2024-02-13
-$206.00M
derived: sum of 4 quarters · filed 2024-02-13
2021-12-31$21.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13
$52.00M
derived: sum of 2 quarters · filed 2024-02-13
$50.00M
derived: sum of 3 quarters · filed 2024-02-13
-$183.00M
10-K · filed 2024-02-13
-$142.00M
10-K · filed 2022-02-09
2021-09-30$31.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26
$29.00M
derived: sum of 2 quarters · filed 2022-10-26
-$204.00M
10-Q · filed 2022-10-26
-$168.00M
10-Q · filed 2021-10-27
-$210.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27
-$235.00M
10-Q · filed 2022-07-27
-$204.00M
10-Q · filed 2021-07-28
-$241.00M
derived: sum of 3 quarters · filed 2023-02-14
-$192.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$233.00M
10-Q · filed 2022-04-29
-$239.00M
derived: sum of 2 quarters · filed 2023-02-14
-$190.00M
derived: sum of 3 quarters · filed 2023-02-14
-$140.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$43.00M
derived: sum of 2 quarters · filed 2023-02-14
$93.00M
derived: sum of 3 quarters · filed 2023-02-14
$134.00M
10-K · filed 2023-02-14
$177.00M
10-K · filed 2021-02-10
2020-09-30$49.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
$99.00M
derived: sum of 2 quarters · filed 2021-10-27
$140.00M
10-Q · filed 2021-10-27
$145.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-06-30$50.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
$91.00M
10-Q · filed 2021-07-28
$92.00M
10-Q · filed 2020-08-06
$96.00M
derived: sum of 3 quarters · filed 2022-02-09
$103.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-03-31$41.00M
10-Q · filed 2021-04-29
$42.00M
10-Q · filed 2020-05-07
$46.00M
derived: sum of 2 quarters · filed 2022-02-09
$53.00M
derived: sum of 3 quarters · filed 2022-02-09
$61.00M
derived: sum of 4 quarters · filed 2022-02-09
2019-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
$12.00M
derived: sum of 2 quarters · filed 2022-02-09
$20.00M
derived: sum of 3 quarters · filed 2022-02-09
$26.00M
10-K · filed 2022-02-09
$22.00M
10-K · filed 2020-02-24
2019-09-30$7.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$15.00M
derived: sum of 2 quarters · filed 2020-11-05
$21.00M
10-Q · filed 2020-11-05
$23.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30$8.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$14.00M
10-Q · filed 2020-08-06
$16.00M
derived: sum of 3 quarters · filed 2021-02-10
$32.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31$6.00M
10-Q · filed 2020-05-07
$8.00M
derived: sum of 2 quarters · filed 2021-02-10
$24.00M
derived: sum of 3 quarters · filed 2021-02-10
$37.00M
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10
$18.00M
derived: sum of 2 quarters · filed 2021-02-10
$31.00M
derived: sum of 3 quarters · filed 2021-02-10
$45.00M
10-K · filed 2021-02-10
$44.00M
10-K · filed 2019-02-25
2018-09-30$16.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$29.00M
derived: sum of 2 quarters · filed 2019-10-31
$43.00M
10-Q · filed 2019-10-31
$48.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30$13.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
$27.00M
10-Q · filed 2019-07-25
$32.00M
derived: sum of 3 quarters · filed 2020-02-24
$18.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31$14.00M
10-Q · filed 2019-04-25
$29.00M
10-Q · filed 2018-04-26
$19.00M
derived: sum of 2 quarters · filed 2020-02-24
$5.00M
derived: sum of 3 quarters · filed 2020-02-24
-$73.00M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
-$9.00M
derived: sum of 2 quarters · filed 2020-02-24
-$87.00M
derived: sum of 3 quarters · filed 2020-02-24
-$120.00M
10-K · filed 2020-02-24
-$92.00M
10-K · filed 2018-02-13
2017-09-30-$14.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25
-$92.00M
derived: sum of 2 quarters · filed 2018-10-25
-$125.00M
10-Q · filed 2018-10-25
-$108.00M
10-Q · filed 2017-10-26
-$145.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-06-30-$78.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26
-$111.00M
10-Q · filed 2018-07-26
-$99.00M
10-Q · filed 2017-07-27
-$131.00M
derived: sum of 3 quarters · filed 2019-02-25
-$99.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-03-31-$33.00M
10-Q · filed 2018-04-26
-$53.00M
derived: sum of 2 quarters · filed 2019-02-25
-$21.00M
derived: sum of 3 quarters · filed 2019-02-25
-$7.00M
derived: sum of 4 quarters · filed 2019-02-25
2016-12-31-$20.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
$12.00M
derived: sum of 2 quarters · filed 2019-02-25
$26.00M
derived: sum of 3 quarters · filed 2019-02-25
$36.00M
10-K · filed 2019-02-25
$44.00M
10-K · filed 2017-02-21
2016-09-30$32.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26
$46.00M
derived: sum of 2 quarters · filed 2017-10-26
$56.00M
10-Q · filed 2017-10-26
$24.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-30$14.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27
$24.00M
10-Q · filed 2017-07-27
-$8.00M
derived: sum of 3 quarters · filed 2018-02-13
$142.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-31$10.00M
10-Q · filed 2017-04-27
-$22.00M
derived: sum of 2 quarters · filed 2018-02-13
$128.00M
derived: sum of 3 quarters · filed 2018-02-13
-$26.00M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-31-$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$118.00M
derived: sum of 2 quarters · filed 2018-02-13
-$36.00M
derived: sum of 3 quarters · filed 2018-02-13
-$15.00M
10-K · filed 2018-02-13
-$594.00M
10-K · filed 2016-02-12
2015-09-30$150.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27
-$4.00M
derived: sum of 2 quarters · filed 2016-10-27
$17.00M
10-Q · filed 2016-10-27
-$306.00M
10-Q · filed 2015-10-27
-$524.00M
derived: sum of 4 quarters · filed 2017-02-21
2015-06-30-$154.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28
-$133.00M
10-Q · filed 2016-07-28
-$671.00M
10-Q · filed 2015-07-23
-$674.00M
derived: sum of 3 quarters · filed 2017-02-21
-$309.00M
derived: sum of 4 quarters · filed 2017-02-21
2015-03-31$21.00M
10-Q · filed 2016-04-28
$234.00M
10-Q · filed 2015-04-28
-$520.00M
derived: sum of 2 quarters · filed 2017-02-21
-$155.00M
derived: sum of 3 quarters · filed 2017-02-21
-$220.00M
derived: sum of 4 quarters · filed 2017-02-21
2014-12-31-$541.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21
-$176.00M
derived: sum of 2 quarters · filed 2017-02-21
-$241.00M
derived: sum of 3 quarters · filed 2017-02-21
$21.00M
10-K · filed 2017-02-21
$567.00M
10-K · filed 2015-02-13
2014-09-30$365.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27
$300.00M
derived: sum of 2 quarters · filed 2015-10-27
$562.00M
10-Q · filed 2015-10-27
$560.00M
10-Q · filed 2014-10-24
$560.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-30-$65.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23
$197.00M
10-Q · filed 2015-07-23
$118.00M
10-Q · filed 2014-07-24
$195.00M
derived: sum of 3 quarters · filed 2016-02-12
$195.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-31$262.00M
10-Q · filed 2015-04-28
$214.00M
10-Q · filed 2014-04-29
$260.00M
derived: sum of 2 quarters · filed 2016-02-12
$260.00M
derived: sum of 3 quarters · filed 2016-02-12
$268.00M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
-$2.00M
derived: sum of 2 quarters · filed 2016-02-12
$6.00M
derived: sum of 3 quarters · filed 2016-02-12
$9.00M
10-K · filed 2016-02-12
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24
$8.00M
derived: sum of 2 quarters · filed 2014-10-24
$11.00M
10-Q · filed 2014-10-24
$67.00M
derived: sum of 4 quarters · filed 2015-02-13
2013-06-30$8.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24
$11.00M
10-Q · filed 2014-07-24
$67.00M
derived: sum of 3 quarters · filed 2015-02-13
$59.00M
derived: sum of 4 quarters · filed 2015-02-13
2013-03-31$3.00M
10-Q · filed 2014-04-29
$59.00M
derived: sum of 2 quarters · filed 2015-02-13
$51.00M
derived: sum of 3 quarters · filed 2015-02-13
$48.00M
derived: sum of 4 quarters · filed 2015-02-13
2012-12-31$56.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13
$48.00M
derived: sum of 2 quarters · filed 2015-02-13
$45.00M
derived: sum of 3 quarters · filed 2015-02-13
$35.00M
10-K · filed 2015-02-13
2012-09-30-$8.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23
-$11.00M
derived: sum of 2 quarters · filed 2013-10-23
-$21.00M
10-Q · filed 2013-10-23
-$12.00M
derived: sum of 4 quarters · filed 2014-02-14
2012-06-30-$3.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25
-$13.00M
10-Q · filed 2013-07-25
-$4.00M
derived: sum of 3 quarters · filed 2014-02-14
$21.00M
derived: sum of 4 quarters · filed 2014-02-14
2012-03-31-$10.00M
10-Q · filed 2013-04-25
-$1.00M
derived: sum of 2 quarters · filed 2014-02-14
$24.00M
derived: sum of 3 quarters · filed 2014-02-14
$26.00M
derived: sum of 4 quarters · filed 2014-02-14
2011-12-31$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14
$34.00M
derived: sum of 2 quarters · filed 2014-02-14
$36.00M
derived: sum of 3 quarters · filed 2014-02-14
$147.00M
10-K · filed 2014-02-14
2011-09-30$25.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24
$27.00M
derived: sum of 2 quarters · filed 2012-10-24
$138.00M
10-Q · filed 2012-10-24
$136.00M
derived: sum of 4 quarters · filed 2013-02-15
2011-06-30$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25
$113.00M
10-Q · filed 2012-07-25
$111.00M
derived: sum of 3 quarters · filed 2013-02-15
$130.00M
derived: sum of 4 quarters · filed 2013-02-15
2011-03-31$111.00M
10-Q · filed 2012-04-26
$109.00M
derived: sum of 2 quarters · filed 2013-02-15
$128.00M
derived: sum of 3 quarters · filed 2013-02-15
2010-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$17.00M
derived: sum of 2 quarters · filed 2013-02-15
$32.00M
10-K · filed 2013-02-15
2010-09-30$19.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27
$34.00M
10-Q · filed 2011-10-27
2010-06-30$15.00M
10-Q · filed 2011-07-28
2009-12-31$367.00M
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64